Diabetes Clinical Trials in Washington

Showing 21-40 of 192 trials

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

NCT05224258

This global study (US, Canada, and Australia) will evaluate the safety and effectiveness of the MiniMed 780G system in type 1 adult and pediatric subjects utilizing Fiasp (insulin aspart injection) in a home setting.

Type 1 Diabetes

Medtronic Diabetes240 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Fresno, California, United States • Sacramento, California, United States +15 more locations

COMPLETEDPHASE334 miles

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

NCT05275400

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.

Type 2 Diabetes

Eli Lilly and Company986 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Concord, California, United States • Escondido, California, United States +124 more locations

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Diabetes Trials in Other Cities

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Navigator 1.5 Accuracy Study

Performance of the L-PLUS BGMS by Persons With Diabetes Mellitus

Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System

Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

Continuous Glucose Monitoring During and After Surgery

MIRACLE of LIFE Study

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

The Combined Portfolio Diet and Exercise Study

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Other Conditions in Washington